[Summary] Basic research in cell biology, promotion of clinical applications, an
Hupo Biotechnology (Suzhou) Co., Ltd. is a subsidiary of Hong Kong Life Sciences (Hong Kong stock code 08085), a listed company in Hong Kong, and is registered in the BioBAY in Suzhou Industrial Park. The company's core technology and major projects are various types of specialized stem cell technologies (neural stem cells, pancreatic islet stem cells, kidney stem cells, liver stem cells, adipose stem cells, epidermal stem cells, etc.) and immune cells (CIK, DC, TCL, αβT, γδT).
Hupo Biotechnology (Suzhou) Co., Ltd. is a high-tech biotech enterprise focusing on the field of cell biology and integrating basic research, promotion of clinical applications, and industrialization. Its R&D and production base is located in Rooms 201-206, Building A5, BioBAY, Suzhou Industrial Park, with an area of 2,200 m². The completed cell product R&D and production center complies with EU (A+B) standards, and the cleanliness standard reaches the overall dynamic Class 100 standard. At the same time, the laboratory adopts advanced intelligent monitoring measures (dust particles, temperature, humidity, wind pressure, etc.), with various monitoring indicators under real-time online monitoring and remote alarm. The management system has passed ISO9001 certification.
As a high-tech enterprise specializing in basic research, clinical research, clinical application, and industrialization in the field of cell biology, the company is positioned as a transformation base for integrating, grafting, and translating domestic and foreign scientific research achievements. The company, guided by "market orientation," has formed strategic cooperation with multiple universities and laboratory teams at home and abroad, such as the Stem Cell Experiment Center of the University of Bologna in Italy, the Cellular Immunology Center of the University of Tokyo in Japan, the Stem Cell Center and Clinical Transformation Center of Tongji University, the State Key Laboratory of Oncogenes of Shanghai Jiao Tong University, and the State Key Laboratory of Craniocerebral Diseases of Ningxia, enabling the company to be at the * level in technological R&D.
:*
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows